Moreover, LKB1 in HCC regulates the Akt-survival pathway independently of phosphoinositide 3-kinase (PI3K) and mammalian target of rapamycin (mTOR) [12]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.